PROCEPT BioRobotics Corporation
PROCEPT BioRobotics Corporation（PRCT）股价预测与分析师目标价
华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。
prct · 股价预测 · 15 位分析师（近3月）· FMP · 更新于 2026年6月8日
分析师评级与共识
基于过去 3 个月内 15 位华尔街分析师
Buy
15 位分析师
共识
评级分布
12 个月目标价
High
$62.00
Consensus
$40.25
+41.0% upside
Low
$30.00
Median: $34.5 · Last Close: $28.54
12 个月目标价预测
历史收盘价 + 分析师 12 个月目标价预测区间
Consensus Target
$40.25
41.0% upside
High Target
$62
117.2%
Low Target
$30
5.1%
Current Price
$28.54
as of today
Based on analyst price targets, the PRCT stock price prediction for the next 12 months ranges from $30 to $62. The consensus PRCT price forecast of $40.25 implies 41.0% upside from the current price of $28.54.
短期股价预测
算法生成 · 每日更新
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $28.61 | ↑ 0.24% |
1-day model range: $28.37–$28.85. Peak: $28.85 (+0.24%).
长期股价预测
年度股价预测 · 2027 / 2028 / 2029 / 2030 / 2031
| Year | Avg Price | Change |
|---|---|---|
| 2027 | $16 | -43.9% |
| 2028 | $12 | -57.5% |
| 2029 | $11 | -63.1% |
| 2030 | $10 | -65.8% |
| 2031 | — | -67.2% |
基于技术分析的股价预测
14 项技术面信号（SMA×6 + EMA×6 + RSI + MACD）· EEAT 方法论透明
Market Sentiment
BULLISH
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · PRCT · Jun 8, 2026
最新分析师评级与调整
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-04-30 | Piper Sandler | Maintains | Overweight→Overweight |
| 2026-03-02 | Truist Securities | Maintains | Buy→Buy |
| 2026-02-26 | Oppenheimer | Downgrade ↓ | Outperform→Perform |
| 2026-02-26 | Wells Fargo | Maintains | Overweight→Overweight |
| 2026-02-26 | B of A Securities | Downgrade ↓ | Neutral→Underperform |
| 2026-02-26 | Leerink Partners | Maintains | Outperform→Outperform |
| 2026-02-26 | Piper Sandler | Maintains | Overweight→Overweight |
| 2026-02-26 | TD Cowen | Maintains | Buy→Buy |
| 2025-12-18 | Truist Securities | Maintains | Buy→Buy |
| 2025-12-08 | B of A Securities | Downgrade ↓ | Buy→Neutral |
Wall Street analysts have recently issued updated ratings on PROCEPT BioRobotics Corporation (PRCT) stock. Of the recent 60 rating actions, 1 were upgrades and 3 were downgrades. 15 analysts currently cover PRCT.
分析师推荐趋势
PRCT analyst recommendation trends show stable buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 1 per month.
财务预测：EPS 与营收一致预期
Revenue This Year
$399M
↓ 31.8% YoY
Revenue Next Year
$492M
↑ 23.3% YoY
EPS This Year
$-1.53
EPS Next Year
$-0.92
↓ 40.0% YoY
EPS ForecastReported vs Estimated
Analysts forecast PRCT EPS of $-1.53 for the current fiscal year, based on estimates from 8 analysts. The PRCT revenue forecast is $399M for the current year. These are analyst consensus estimates via FMP / S&P Global.
关于预测与目标价
PRCT 股价预测由两类独立数据源支撑：来自 15 位华尔街分析师（S&P Global / FMP）的共识评级，以及基于历史日终价计算的技术分析。PRCT 的共识目标价为 $40.25（+41.0% 上行空间），分析师共识为 Buy。
PRCT 的短期预测（明日）为 $28.61（+0.24%）。 PRCT 对 2027 年的股价预测均值为 $16。 PRCT 对 2030 年的预测区间为 $9–$11。
PROCEPT BioRobotics Corporation 在 NASDAQ 上市，代码 PRCT。PRCT 在 2027 年的整体展望偏积极，在覆盖分析师中约 73% 对应 Buy 共识。
常见问题
PRCT 预测 · 8 个问题根据 15 位华尔街分析师，PRCT 的 12 个月平均目标价为 $40.25，最高 $62.00、最低 $30.00。若有图表，中位目标价可在上方查看。相对当前价 $28.54，隐含约 +41.0% 的上行空间。
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.